CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
61 hedge funds and large institutions have $57.1M invested in Concert Pharmaceuticals, Inc. in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 21 increasing their positions, 27 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
61
Holders Change
-18
Holders Change %
-22.78%
% of All Funds
1.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
21
Reduced
27
Closed
18
Calls
$100K
Puts
$71K
Net Calls
+$29K
Net Calls Change
-$40K
Top Buyers
Top Sellers
| 1 |
Renaissance Technologies
New York
|
$2.44M |
| 2 |
Millennium Management
New York
|
$3.69M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
$2.43M |
| 4 |
Morgan Stanley
New York
|
$651K |
| 5 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
76
Nisa Investment Advisors
St. Louis,
Missouri
| – | -$4 | -910 | Closed |
|
77
New York State Common Retirement Fund
Albany,
New York
| – | -$1K | -267 | Closed |
|